MENINGOCOCCAL POLYSACCHARIDE VACCINE A+C Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

meningococcal polysaccharide vaccine a+c

sanofi pasteur. - neisseria meningitidis a,ΠΟΛΥΣΑΚΧΑΡΊΤΗ, ΜΗΝΙΓΓΙΤΙΔΌΚΟΚΚΟΣ c,ΠΟΛΥΣΑΚΧΑΡΊΤΗ - powder & solvent for suspension for injection - 100mcg - 8000000697 - neisseria meningitidis a,polysaccharide - 50 ug; 8000000698 - neisseria meningitidis c,polysaccharide - 50 ug - meningococcus, bivalent purified polysacc. antigen

RABITEC (10^6.8 FFU to 10^8.1 FFU)/1.7ml ΠΟΣΙΜΟ ΕΝΑΙΩΡΗΜΑ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

rabitec (10^6.8 ffu to 10^8.1 ffu)/1.7ml ποσιμο εναιωρημα

ceva sante animale, libourne, france (0000006753) zi la ballastiere,,,33500 libourne,fr - attenuated live rabies vaccine virus, strain spbn gasgas - ΠΟΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - (10^6.8 ffu to 10^8.1 ffu)/1.7ml - attenuated live rabies vaccine virus, strain spbn gasgas 0,00 oral.susp (10^6.8 ffu to 10^8.1 ffu)/1.7ml - live viral vaccines - Νυκτερευτές (racoon dogs); Αλεπούδες - Χρόνοι αναμονής: Νυκτερευτές (racoon dogs); Αλεπούδες

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - Εμβόλια - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. Η χρήση αυτού του εμβολίου θα πρέπει να γίνεται σύμφωνα με τις επίσημες συστάσεις.

Purevax RCP FeLV Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

purevax rcp felv

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Purevax RC Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

purevax rc

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

Purevax RCP Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

purevax rcp

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

OVAX M.G.S. Inactivated vaccine in suspension for injection for sheep Κύπρος - Ελληνικά - Κυπριακή Δημοκρατία, Υπουργείο Γεωργίας, Αγροτικής Ανάπτυξης και Περιβάλλοντος, Κτηνιατρικές Υπηρεσίες

ovax m.g.s. inactivated vaccine in suspension for injection for sheep

fatro s.p.a., italy - ΑΔΡΑΝΟΠΟΙΗΜΈΝΟ s. aureus ΠΟΛΙΤΙΣΜΏΝ 16 x 10e9 cfu ΣΤΑΦΥΛΟΚΟΚΚΙΚΈΣ ΈΝΑ-ΑΝΑΤΟΞΊΝΗ 120 ΑΙΜΟΛΥΤΙΚΉ ΜΟΝΆΔΕΣ ΣΤΑΦΥΛΟΚΟΚΚΙΚΈΣ Β-ΑΝΑΤΟΞΊΝΗ 2000 ΑΙΜΟΛΥΤΙΚΉ ΜΟΝΆΔΕΣ - suspension for injection - vaccine - sheep

PreHevbri Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

prehevbri

vbi vaccines b.v. - επιφανειακό αντιγόνο ηπατίτιδας Β - Ηπατίτιδα Β - Εμβόλια - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.

MENJUGATE KIT Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

menjugate kit

glaxosmithkline vaccines s.r.l., siena, italy - ΝΕΙΣΣΕΡΙΑ ΜΕΝΙΝΓΚΙΤΙΔΗΣ Γ (str c11) oligosaccharide conj. Στο corynebacterium diphtheriae crm-197 prot - ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - 10 mcg/0,5 ml (dose) - ineof01775 - neisseria meningitidis c (str c11) oligosaccharide conj. to corynebacterium diphtheriae crm-197 prot - 0.000000 mcg - meningococcus c, purified polysaccharides antigen conjugated

MENJUGATE Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

menjugate

glaxosmithkline vaccines s.r.l., siena, italy - meningococcal group c (oligosaccharide ΣΥΝΔΕΔΕΜΕΝΟ ΣΤΗΝ diphtheria crm 197 protein) - ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - 10mcg/0,5ml(dose) - ineof01340 - meningococcal group c (oligosaccharide conjugated to diphtheria crm 197 protein) - 0.000000 - other meningococcal monovalent purified polysaccharides antigen